Cargando…
Cell‐cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone
BACKGROUND: Prostate cancer treatment aims to prevent metastases and disease‐specific mortality. Pathologic parameters have limited ability to predict these outcomes, but biomarkers can improve risk discrimination. We evaluated the ability of cell‐cycle progression and combined cell‐cycle risk score...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898933/ https://www.ncbi.nlm.nih.gov/pubmed/33475174 http://dx.doi.org/10.1002/pros.24103 |